Buy Trillium Therapeutics Stock | TRIL Stock Price & Latest News | Public.com
TRIL

Trillium Therapeutics

$0.00 (0.00%)Today
    View Trillium Therapeutics (TRIL) stock trends here

    About TRIL

    Trillium Therapeutics Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. Its pipeline is comprised of TTI-621, TTI-622, and TTI-10001 (Sting Agonist). The company was founded on March...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.21
    -0.42
    -0.63
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.17

    Actual EPS
    Q1 2021

    Stats

    Market Cap$931,18M
    Volume2,89k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$20.96
    1 Year Low$2.50
    Open$10.66
    High$11.35
    Low$10.42

    Buy any stock with any amount of money.

    Download the App
    Download the app